Term | Pathway | Count | Pop Hits | P Value |
---|---|---|---|---|
hsa05200 | Pathways in cancer | 41 | 393 | 6.63E−27 |
hsa05161 | Hepatitis B | 27 | 145 | 1.73E−23 |
hsa05205 | Proteoglycans in cancer | 23 | 200 | 3.70E−15 |
hsa04151 | PI3K-Akt signaling pathway | 23 | 345 | 2.43E−10 |
hsa05166 | HTLV-I infection | 19 | 254 | 2.58E−09 |
hsa05206 | MicroRNAs in cancer | 19 | 286 | 1.70E−08 |
hsa05152 | Tuberculosis | 18 | 177 | 6.66E−11 |
hsa04510 | Focal adhesion | 18 | 206 | 7.34E−10 |
hsa05219 | Bladder cancer | 17 | 41 | 1.18E−20 |
hsa04066 | HIF-1 signaling pathway | 17 | 96 | 4.41E−14 |
hsa05160 | Hepatitis C | 17 | 133 | 8.19E−12 |
hsa04010 | MAPK signaling pathway | 17 | 253 | 1.11E−07 |
hsa05210 | Colorectal cancer | 16 | 62 | 7.74E−16 |
hsa05212 | Pancreatic cancer | 16 | 65 | 1.78E−15 |
hsa05215 | Prostate cancer | 16 | 88 | 2.09E−13 |
hsa05142 | Chagas disease (American trypanosomiasis) | 16 | 104 | 2.67E−12 |
hsa05145 | Toxoplasmosis | 16 | 110 | 6.18E−12 |
hsa05164 | Influenza A | 16 | 174 | 4.54E−09 |
hsa05223 | Non-small cell lung cancer | 15 | 56 | 4.75E−15 |
hsa04012 | ErbB signaling pathway | 15 | 87 | 3.24E−12 |